Seamless management of biliary atresia in England and Wales (1999--2002).
Saved in:
| Title: | Seamless management of biliary atresia in England and Wales (1999--2002). |
|---|---|
| Authors: | Davenport, Mark, De Goyet, J. De Ville, Stringer, M. D., Mieli-Vergani, G., Kelly, D. A., McClean, P., Spitz, L. |
| Source: | Lancet. 4/24/2004, Vol. 363 Issue 9418, p1354-1357. 4p. |
| Subjects: | Biliary atresia, Infant disease treatment, Liver transplantation, Neonatal jaundice, Medical care research, Medical research, Therapeutics |
| Geographic Terms: | United Kingdom |
| Abstract: | Background Before 1999, infants born in the UK with suspected biliary atresia were investigated in regional centers, and, if confirmed, a Kasai operation was done there. Since 1999, all infants with suspected biliary atresia in England and Wales, UK, have been referred to one of three designated centers where both the Kasai operation and liver transplantation (if necessary) could be done. Methods We assessed clearance of jaundice (bilirubin <20 mol/L) as an early outcome in all cases of biliary atresia referred from one of the three centers. We then estimated survival using the Kaplan-Meier method with endpoints of liver transplantation or death. Findings 148 infants with biliary atresia were treated between January, 1999, and June, 2002. A primary portoenterostomy was done in 142 (96%) infants and a primary liver transplant in five (3%). One child died before any intervention. Early clearance of jaundice after portoenterostomy was achieved in 81 of 142 (57%) infants. Liver transplantation was done in 52 (37%) of those undergoing portoenterostomy. 13 (9%) infants died. Of the 135 children who survived, 84 (62%) still have their native liver and 51 (38%) had transplantation. The median follow-up of survivors was 2.13 (range 0.5--4.1) years. The overall 4-year estimated actuarial survival was 89% (95% CI 82--94). The 4-year estimated actuarial survival with native liver was 51% (42--59%). Interpretation Our early results suggest that surgical outcome can be improved by centralization of care to supraregional centers. [ABSTRACT FROM AUTHOR] |
| Copyright of Lancet is the property of Lancet and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 12902141 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Seamless management of biliary atresia in England and Wales (1999--2002). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Davenport%2C+Mark%22">Davenport, Mark</searchLink><br /><searchLink fieldCode="AR" term="%22De+Goyet%2C+J%2E+De+Ville%22">De Goyet, J. De Ville</searchLink><br /><searchLink fieldCode="AR" term="%22Stringer%2C+M%2E+D%2E%22">Stringer, M. D.</searchLink><br /><searchLink fieldCode="AR" term="%22Mieli-Vergani%2C+G%2E%22">Mieli-Vergani, G.</searchLink><br /><searchLink fieldCode="AR" term="%22Kelly%2C+D%2E+A%2E%22">Kelly, D. A.</searchLink><br /><searchLink fieldCode="AR" term="%22McClean%2C+P%2E%22">McClean, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Spitz%2C+L%2E%22">Spitz, L.</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Lancet%22">Lancet</searchLink>. 4/24/2004, Vol. 363 Issue 9418, p1354-1357. 4p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Biliary+atresia%22">Biliary atresia</searchLink><br /><searchLink fieldCode="DE" term="%22Infant+disease+treatment%22">Infant disease treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Liver+transplantation%22">Liver transplantation</searchLink><br /><searchLink fieldCode="DE" term="%22Neonatal+jaundice%22">Neonatal jaundice</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+care+research%22">Medical care research</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+research%22">Medical research</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%22">Therapeutics</searchLink> – Name: SubjectGeographic Label: Geographic Terms Group: Su Data: <searchLink fieldCode="DE" term="%22United+Kingdom%22">United Kingdom</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Background Before 1999, infants born in the UK with suspected biliary atresia were investigated in regional centers, and, if confirmed, a Kasai operation was done there. Since 1999, all infants with suspected biliary atresia in England and Wales, UK, have been referred to one of three designated centers where both the Kasai operation and liver transplantation (if necessary) could be done. Methods We assessed clearance of jaundice (bilirubin <20 mol/L) as an early outcome in all cases of biliary atresia referred from one of the three centers. We then estimated survival using the Kaplan-Meier method with endpoints of liver transplantation or death. Findings 148 infants with biliary atresia were treated between January, 1999, and June, 2002. A primary portoenterostomy was done in 142 (96%) infants and a primary liver transplant in five (3%). One child died before any intervention. Early clearance of jaundice after portoenterostomy was achieved in 81 of 142 (57%) infants. Liver transplantation was done in 52 (37%) of those undergoing portoenterostomy. 13 (9%) infants died. Of the 135 children who survived, 84 (62%) still have their native liver and 51 (38%) had transplantation. The median follow-up of survivors was 2.13 (range 0.5--4.1) years. The overall 4-year estimated actuarial survival was 89% (95% CI 82--94). The 4-year estimated actuarial survival with native liver was 51% (42--59%). Interpretation Our early results suggest that surgical outcome can be improved by centralization of care to supraregional centers. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Lancet is the property of Lancet and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=12902141 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0140-6736(04)16045-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 4 StartPage: 1354 Subjects: – SubjectFull: Biliary atresia Type: general – SubjectFull: Infant disease treatment Type: general – SubjectFull: Liver transplantation Type: general – SubjectFull: Neonatal jaundice Type: general – SubjectFull: Medical care research Type: general – SubjectFull: Medical research Type: general – SubjectFull: Therapeutics Type: general – SubjectFull: United Kingdom Type: general Titles: – TitleFull: Seamless management of biliary atresia in England and Wales (1999--2002). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Davenport, Mark – PersonEntity: Name: NameFull: De Goyet, J. De Ville – PersonEntity: Name: NameFull: Stringer, M. D. – PersonEntity: Name: NameFull: Mieli-Vergani, G. – PersonEntity: Name: NameFull: Kelly, D. A. – PersonEntity: Name: NameFull: McClean, P. – PersonEntity: Name: NameFull: Spitz, L. IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 04 Text: 4/24/2004 Type: published Y: 2004 Identifiers: – Type: issn-print Value: 01406736 Numbering: – Type: volume Value: 363 – Type: issue Value: 9418 Titles: – TitleFull: Lancet Type: main |
| ResultId | 1 |